866772-52-3
中文名稱
BenzeneacetaMide, α-(cyclopentylMethyl)-N-(5-Methoxythiazolo[5,4-b]pyridin-2-yl)-4-[(4-Methyl-1-piperazinyl)sulfonyl]-, (αR)-
英文名稱
BenzeneacetaMide, α-(cyclopentylMethyl)-N-(5-Methoxythiazolo[5,4-b]pyridin-2-yl)-4-[(4-Methyl-1-piperazinyl)sulfonyl]-, (αR)-
CAS
866772-52-3
分子式
C26H33N5O4S2
分子量
543.7
MOL 文件
866772-52-3.mol
866772-52-3 結(jié)構(gòu)式
基本信息
中文別名
化合物 T32612 英文別名
LBX192NVP-LBX192
NVP-LBX-192
NVP-LBX 192
(R)-3-cyclopentyl-N-(5-methoxy-thiazolo[5,4-b]pyridin-2-yl)-2-[4-(4-methyl-piperazine-1-sulfonyl)phenyl]propionamide
(2R)-3-cyclopentyl-N-(5-methoxy-[1,3]thiazolo[5,4-b]pyridin-2-yl)-2-[4-(4-methylpiperazin-1-yl)sulfonylphenyl]propanamide
BenzeneacetaMide, α-(cyclopentylMethyl)-N-(5-Methoxythiazolo[5,4-b]pyridin-2-yl)-4-[(4-Methyl-1-piperazinyl)sulfonyl]-, (αR)-
應(yīng)用領(lǐng)域
用途一
LBX192, also known as NVP-LBX192, is a Liver Targeted Glucokinase Activator. LBX192 activated the GK enzyme in vitro at low nM concentrations and significantly reduced glucose levels during an oral glucose tolerance test in normal as well as diabetic mice. A GK activator has the promise of potentially affecting both the beta-cell of the pancreas, by improving glucose sensitive insulin secretion, as well as the liver, by reducing uncontrolled glucose output and restoring post prandial glucose uptake and storage as glycogen.